VIVA BIOTECH (01873) issues 8.58 million share purchase rights.
VIA Life Sciences (01873) announced that, in accordance with its share purchase plan adopted on April 14, 2019, the company granted share purchase rights to several eligible participants on December 2, 2025, to subscribe for a total of 8.58 million ordinary shares of the company.
VIVA BIOTECH (01873) announced that the company has granted stock options to a number of eligible participants on December 2, 2025, in accordance with the stock option plan adopted on April 14, 2019, to subscribe for a total of 8.58 million ordinary shares of the company.
Related Articles
HUITONGDA NET (09878) spent approximately HK$496,200 to repurchase 50,000 shares on December 2nd.
ASIAN CITRUS (00073): Selling a total of 800 shares of NVIDIA stocks.
Jiangsu Hengrui Pharmaceuticals (01276): As of the end of November, it has repurchased a total of 8.89 million A shares.
HUITONGDA NET (09878) spent approximately HK$496,200 to repurchase 50,000 shares on December 2nd.
ASIAN CITRUS (00073): Selling a total of 800 shares of NVIDIA stocks.
Jiangsu Hengrui Pharmaceuticals (01276): As of the end of November, it has repurchased a total of 8.89 million A shares.
